 |
Articles: Drug/Product Approvals |
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Free full text
Prior Articles
Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder
Genzyme, 11/19/09
Free full text
Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09 Genzyme Receives Complete Response Letter on Lumizyme Application
Genzyme, 11/17/09
Free full text
Human genome sciences receives complete response letter from fda for raxibacumab biologics license application
Human Genome Sciences, 11/17/09
Free full text
Panenza, Sanofi Pasteurs Influenza A(H1N1) 2009 Vaccine, Approved in France
Sanofi-aventis, 11/17/09
Free full text
Novartis receives approval in Switzerland for Celtura, a cell culture-based Influenza A(H1N1) pandemic vaccine
Novartis, 11/16/09
Free full text
Covidien Introduces First FDA-Approved Spine Sealant
Covidien, 11/13/09 Pandemic 2009 Influenza Update: US FDA approves GSKs pandemic H1N1 vaccine
GlaxoSmithKline, 11/12/09
Free full text
Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09
Free full text
Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09 FDA Approves Pennsaid(R) Topical Solution
Covidien, 11/10/09 Anti-Malignancy Agent Avastin: Obtained Approval for Additional Indication of Non-Small Cell Lung Cancer
Chugai Pharmaceutical Co., 11/10/09
Free full text
GlaxoSmithKline and XenoPort announce extension of GSK1838262 FDA review date to 2010
GlaxoSmithKline, 11/10/09
Free full text
Anti-Malignancy Agent/Anti-VEGF Humanized Monoclonal Antibody, Avastin: Application for Approval of Additional Indication of Breast Cancer
Chugai Pharmaceutical Co., 11/09/09
Free full text
United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food
BioMarin, 11/06/09
Free full text
FDA Approves Labeling Update for REYATAZ (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
Bristol Myers-Squibb Company, 11/06/09
Free full text
Novartis receives regulatory approval in Germany for Celtura, a cell culture-based Influenza A(H1N1) pandemic vaccine
Novartis, 11/06/09
Free full text
Agfa to Demonstrate Images Within EHRs
HealthDataManagement, 11/06/09 Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product
Covidien, 11/05/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
